JUSTIN FARMER

JBSA LACKLAND, TX NPI 1285986646

General Payments — all program years on this page

$565.22

  • Category: General Payments
  • Program years: PY2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $565.22 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $565.2222

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $565.2222

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100207556 Corium, LLC $15.96 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100207560 Corium, LLC $24.45 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107090562 ABBVIE INC. $13.97 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119069184 Otsuka America Pharmaceutical, Inc. $19.55 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119069186 Otsuka America Pharmaceutical, Inc. $12.36 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119069188 Otsuka America Pharmaceutical, Inc. $15.47 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119069190 Otsuka America Pharmaceutical, Inc. $121.86 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120497481 Alkermes, Inc. $23.64 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120497483 Alkermes, Inc. $28.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133941886 Vanda Pharmaceuticals Inc. $21.18 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137741448 Takeda Pharmaceuticals U.S.A., Inc. $15.26 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137741450 Takeda Pharmaceuticals U.S.A., Inc. $23.12 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143445417 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.22 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143445421 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.08 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143445424 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.55 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146019769 Lundbeck LLC $21.45 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147201491 Tris Pharma Inc $15.83 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147201493 Tris Pharma Inc $16.30 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147201495 Tris Pharma Inc $18.22 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147201497 Tris Pharma Inc $18.56 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373636 Axsome Therapeutics, Inc. $29.22 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373638 Axsome Therapeutics, Inc. $35.97 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.